Literature DB >> 21653924

A multi-country qualitative study of clinicians' and patients' views on point of care tests for lower respiratory tract infection.

Fiona Wood1, Lucy Brookes-Howell, Kerenza Hood, Lucy Cooper, Theo Verheij, Herman Goossens, Paul Little, Maciek Godycki-Cwirko, Niels Adriaenssens, Kristin Jakobsen, Christopher C Butler.   

Abstract

BACKGROUND: Point of care tests (POCTs) are being promoted to better target antibiotic prescribing with the aim of improving outcomes and containing antibiotic resistance.
OBJECTIVE: We aimed to explore clinician and patient views about POCTs to assist with the diagnosis and management of lower respiratory tract infection (LRTI) in primary care.
METHODS: Multi-country European qualitative interview study with 80 primary care clinicians and 121 adult patients in nine primary care networks who had recently consulted with symptoms of acute cough/LRTI. Transcripts were subjected to a five-stage analytic framework approach (familiarization, developing a thematic framework from the interview questions and the themes emerging from the data, indexing, charting, and mapping to search for interpretations in the data), with local network facilitators commenting on preliminary reports.
RESULTS: Clinicians who did not routinely use POCTs for acute cough/LRTI felt that the tests' advantages included managing patient expectations for antibiotics. Perceived disadvantages included questionable test performance, problems interpreting results, a detraction from clinical reasoning, costs, time and patients not wanting, or demanding, the tests. Clinicians who routinely used POCTs echoed these disadvantages. Almost all patients would be happy to be managed with the addition of a POCT. Patients with experience of POCTs accepted it as part of routine care.
CONCLUSIONS: Acceptability of POCTs to clinicians is likely to be improved if tests perform well on accuracy, time to result, simplicity and cost. Including POCTs in the routine management of acute cough/LRTI is likely to be acceptable to most patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21653924     DOI: 10.1093/fampra/cmr031

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  31 in total

1.  Antibiotic prescribing for acute respiratory tract infections in primary care: an updated and expanded meta-ethnography.

Authors:  Evi Germeni; Julia Frost; Ruth Garside; Morwenna Rogers; Jose M Valderas; Nicky Britten
Journal:  Br J Gen Pract       Date:  2018-06-18       Impact factor: 5.386

2.  Patient Willingness to Have Tests to Guide Antibiotic Use for Respiratory Tract Infections: From the WWAMI Region Practice and Research Network (WPRN).

Authors:  Malaika Schwartz; Victoria Hardy; Gina A Keppel; William Alto; Jaime Hornecker; Beth Robitaille; Jon Neher; John Holmes; M Ashworth Dirac; Allison M Cole; Matthew Thompson
Journal:  J Am Board Fam Med       Date:  2017 Sep-Oct       Impact factor: 2.657

3.  Clinicians' views and experiences of interventions to enhance the quality of antibiotic prescribing for acute respiratory tract infections.

Authors:  Sibyl Anthierens; Sarah Tonkin-Crine; Jochen W Cals; Samuel Coenen; Lucy Yardley; Lucy Brookes-Howell; Patricia Fernandez-Vandellos; Jaroslaw Krawczyk; Maciek Godycki-Cwirko; Carl Llor; Christopher C Butler; Theo Verheij; Herman Goossens; Paul Little; Nick A Francis
Journal:  J Gen Intern Med       Date:  2014-11-06       Impact factor: 5.128

4.  The Role of Point-of-Care C-Reactive Protein Testing in Antibiotic Prescribing for Respiratory Tract Infections: A Survey among Swiss General Practitioners.

Authors:  Nahara Anani Martínez-González; Andreas Plate; Levy Jäger; Oliver Senn; Stefan Neuner-Jehle
Journal:  Antibiotics (Basel)       Date:  2022-04-19

Review 5.  Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care.

Authors:  Ole Olsen; Siri Aas Smedemark; Rune Aabenhus; Carl Llor; Anders Fournaise; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2022-10-17

6.  C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.

Authors:  Nick A Francis; David Gillespie; Patrick White; Janine Bates; Rachel Lowe; Bernadette Sewell; Rhiannon Phillips; Helen Stanton; Nigel Kirby; Mandy Wootton; Emma Thomas-Jones; Kerenza Hood; Carl Llor; Jochen Cals; Hasse Melbye; Gurudutt Naik; Micaela Gal; Deborah Fitzsimmons; Mohammed Fasihul Alam; Evgenia Riga; Ann Cochrane; Christopher C Butler
Journal:  Health Technol Assess       Date:  2020-03       Impact factor: 4.014

7.  Diagnostics barriers and innovations in rural areas: insights from junior medical doctors on the frontlines of rural care in Peru.

Authors:  Cynthia Fiorella Anticona Huaynate; Monica Jehnny Pajuelo Travezaño; Malena Correa; Holger Mayta Malpartida; Richard Oberhelman; Laura L Murphy; Valerie A Paz-Soldan
Journal:  BMC Health Serv Res       Date:  2015-10-05       Impact factor: 2.655

8.  Perceptions of point-of-care infectious disease testing among European medical personnel, point-of-care test kit manufacturers, and the general public.

Authors:  Wendy E Kaman; Eleni-Rosalina Andrinopoulou; John P Hays
Journal:  Patient Prefer Adherence       Date:  2013-06-19       Impact factor: 2.711

Review 9.  Primary care clinicians' attitudes towards point-of-care blood testing: a systematic review of qualitative studies.

Authors:  Caroline H D Jones; Jeremy Howick; Nia W Roberts; Christopher P Price; Carl Heneghan; Annette Plüddemann; Matthew Thompson
Journal:  BMC Fam Pract       Date:  2013-08-14       Impact factor: 2.497

10.  A qualitative study of GP, NP and patient views about the use of rapid streptococcal antigen detection tests (RADTs) in primary care: 'swamped with sore throats?'.

Authors:  Gerry M Leydon; Lisa McDermott; Mike Moore; Ian Williamson; F D Richard Hobbs; Tessa Lambton; Rebecca Cooper; Hugo Henderson; Paul Little
Journal:  BMJ Open       Date:  2013-04-03       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.